Literature DB >> 30380544

Continuous Veno-Venous Hemodialysis Using the Cardio-Renal Pediatric Dialysis Emergency MachineTM: First Clinical Experiences.

Enrico Vidal1, Enrico Cocchi2, Fabio Paglialonga3, Zaccaria Ricci4, Francesco Garzotto5, Licia Peruzzi2, Luisa Murer6, Claudio Ronco7.   

Abstract

We report the first worldwide experience with continuous veno-venous hemodialysis (CVVHD) in children using the last generation Cardio-Renal Pediatric Dialysis Emergency Machine (CARPEDIEM)TM device. Thirteen children received 1,008 h of CVVHD during 95 sessions, using a 0.15 (n = 7) or a 0.25 m2 (n = 6) hemofilter. The median weight was 3 kg (interquartile range [IQR] 2.5-6.2). In 10 patients, CVVHD was conducted using a 5 Fr double-lumen central vascular access, whereas in 3 children, bigger sizes were used (6.5 and 8 Ch). The median prescribed Qb was 17 mL/min (IQR 10-29.5), with a median Qd of 10 mL/min. Circuits were primed with 5% albumin in 12 out of 13 patients, using anticoagulation with heparin in all 13 cases. The median delivered/prescribed time ratio yielded a 100% result (95-100%). The most common cause for "downtime" was clotting that however occurred in only 3% of all treatments. Survivals at continuous renal replacement therapy discontinuation and ICU discharge were 100 and 69% respectively. The CARPEDIEMTM machine allowed successful delivery of diffusive blood purification modality to very small patients, using small catheters, no blood primes, and excellent concordance between delivered and prescribed treatment duration.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Cardio-renal pediatric dialysis emergency machine; Continuous veno-venous hemodialysis; Infants; Neonates

Mesh:

Year:  2018        PMID: 30380544     DOI: 10.1159/000494437

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  5 in total

1.  Anticoagulation in patients with acute kidney injury undergoing kidney replacement therapy.

Authors:  Rupesh Raina; Ronith Chakraborty; Andrew Davenport; Patrick Brophy; Sidharth Sethi; Mignon McCulloch; Timothy Bunchman; Hui Kim Yap
Journal:  Pediatr Nephrol       Date:  2021-10-19       Impact factor: 3.651

2.  Survival of infants treated with CKRT: comparing adapted adult platforms with the Carpediem™.

Authors:  Stuart L Goldstein; Enrico Vidal; Zaccaria Ricci; Fabio Paglialonga; Licia Peruzzi; Mario Giordano; Nicola Laforgia; Claudio Ronco
Journal:  Pediatr Nephrol       Date:  2021-08-20       Impact factor: 3.651

3.  Pediatric acute kidney injury: new advances in the last decade.

Authors:  Sidharth K Sethi; Timothy Bunchman; Ronith Chakraborty; Rupesh Raina
Journal:  Kidney Res Clin Pract       Date:  2021-03-03

Review 4.  Renal replacement therapies for infants and children in the ICU.

Authors:  Keia R Sanderson; Lyndsay A Harshman
Journal:  Curr Opin Pediatr       Date:  2020-06       Impact factor: 2.893

5.  Towards an Algorithm-Based Tailored Treatment of Acute Neonatal Hyperammonemia.

Authors:  Sunny Eloot; Jonathan De Rudder; Patrick Verloo; Evelyn Dhont; Ann Raes; Wim Van Biesen; Evelien Snauwaert
Journal:  Toxins (Basel)       Date:  2021-07-13       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.